These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37443085)

  • 21. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
    Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
    Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Lateral Pelvic Lymph Node Metastasis in Advanced Low Rectal Cancer Treated With Neoadjuvant Chemotherapy.
    Ishizaki T; Katsumata K; Enomoto M; Mazaki J; Udo R; Tago T; Kasahara K; Kuwabara H; Nagakawa Y; Tsuchida A
    Anticancer Res; 2022 Apr; 42(4):2113-2121. PubMed ID: 35347035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy.
    Reis J; Boavida J; Tran HT; Lyngra M; Reitsma LC; Schandiz H; Melles WA; Gjesdal KI; Geisler J; Geitung JT
    BMC Cancer; 2022 Jun; 22(1):702. PubMed ID: 35752785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of texture analysis on T2-weighted MR for differentiating tumor deposits from mesorectal nodes in rectal cancer patients, in a retrospective cohort.
    Atre ID; Eurboonyanun K; Noda Y; Parakh A; O'Shea A; Lahoud RM; Sell NM; Kunitake H; Harisinghani MG
    Abdom Radiol (NY); 2021 Feb; 46(2):459-468. PubMed ID: 32700214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
    Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of MRI for nodal restaging in rectal cancer: a retrospective study of 166 cases.
    Pangarkar S; Mistry K; Choudhari A; Smriti V; Ahuja A; Katdare A; Engineer R; Ostwal V; Ramadwar M; Saklani A; Baheti AD
    Abdom Radiol (NY); 2021 Feb; 46(2):498-505. PubMed ID: 32813028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging?
    Heijnen LA; Maas M; Beets-Tan RG; Berkhof M; Lambregts DM; Nelemans PJ; Riedl R; Beets GL
    Int J Colorectal Dis; 2016 Jun; 31(6):1157-62. PubMed ID: 27055660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive MR assessment of the microstructure and microcirculation in regional lymph nodes for rectal cancer: a study of intravoxel incoherent motion imaging.
    Yang X; Chen Y; Wen Z; Liu Y; Xiao X; Liang W; Yu S
    Cancer Imaging; 2019 Nov; 19(1):70. PubMed ID: 31685035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer.
    Alberda WJ; Dassen HP; Dwarkasing RS; Willemssen FE; van der Pool AE; de Wilt JH; Burger JW; Verhoef C
    Int J Colorectal Dis; 2013 Apr; 28(4):573-80. PubMed ID: 23001160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
    Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
    Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?
    Gollub MJ; Blazic I; Bates DDB; Campbell N; Knezevic A; Gonen M; Lynn P; Weiser MR; Garcia-Aguilar J; Hötker AM; Cercek A; Saltz L
    Eur Radiol; 2019 Apr; 29(4):1733-1742. PubMed ID: 30280248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent diffusion coefficient for lymph node characterization after chemoradiation therapy for locally advanced rectal cancer.
    Kim SH; Ryu KH; Yoon JH; Lee Y; Paik JH; Kim SJ; Jung HK; Lee KH
    Acta Radiol; 2015 Dec; 56(12):1446-53. PubMed ID: 25425724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Laohawiriyakamol S; Worathanmanon S; Tubtawee T; Kanjanapradit K; Sangkhathat S; Pruphetkaew N; Chongsuvivatwong V
    Asian J Surg; 2021 Jan; 44(1):275-279. PubMed ID: 32712044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Quantitative Dynamic Contrast-Enhanced MRI in Evaluating Regional Lymph Nodes With a Short-Axis Diameter of Less Than 5 mm in Rectal Cancer.
    Yang X; Chen Y; Wen Z; Lu B; Shen B; Xiao X; Yu S
    AJR Am J Roentgenol; 2019 Jan; 212(1):77-83. PubMed ID: 30354269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of remaining tumour involved lymph nodes with MRI in patients with complete luminal response after neoadjuvant treatment of rectal cancer.
    Loftås P; Sturludóttir M; Hallböök O; Almlöv K; Arbman G; Blomqvist L
    Br J Radiol; 2018 Jul; 91(1087):20170938. PubMed ID: 29668301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodal staging in the rectal cancer follow-up MRI after chemoradiotherapy: use of morphology, size, and diffusion criteria.
    Fornell-Perez R; Perez-Alonso E; Aleman-Flores P; Lozano-Rodriguez A; Loro-Ferrer JF
    Clin Radiol; 2020 Feb; 75(2):100-107. PubMed ID: 31515052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-based guidelines for selective neoadjuvant treatment in rectal cancer: Does MRI adequately predict the indication for radiotherapy in daily practice in a large teaching hospital.
    Tersteeg JJC; Crolla RMPH; Gobardhan PD; Kint PAM; Niers-Stobbe I; Boonman-de Winter L; Arnold DE; Rozema T; Schreinemakers JMJ
    Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13190. PubMed ID: 31863608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?
    Heijnen LA; Lambregts DM; Martens MH; Maas M; Bakers FC; Cappendijk VC; Oliveira P; Lammering G; Riedl RG; Beets GL; Beets-Tan RG
    Eur Radiol; 2014 Feb; 24(2):371-9. PubMed ID: 24051676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrimination of metastatic from non-metastatic mesorectal lymph nodes in rectal cancer using quantitative dynamic contrast-enhanced magnetic resonance imaging.
    Yu XP; Wen L; Hou J; Wang H; Lu Q
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):594-600. PubMed ID: 27465339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation.
    Zhang H; Zhang C; Zheng Z; Ye F; Liu Y; Zou S; Zhou C
    Eur Radiol; 2017 Sep; 27(9):3845-3855. PubMed ID: 28168369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.